Clinical Trials Browser

OTHER × Triple Negative Breast Neoplasms × bintrafusp alfa protein, human × Clear all

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Hematologic Neoplasms, Triple Negative Breast Neoplasms

NCT03579472 2022-10-31

M7824 and Eribulin Mesylate in Treating Patients With Metastatic Triple Negative Breast Cancer

Phase 1 Terminated

38 enrolled

Breast

Triple Negative Breast Neoplasms

Clinical Trials

Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases

M7824 and Eribulin Mesylate in Treating Patients With Metastatic Triple Negative Breast Cancer